Developing a new class of engineered live bacterial therapeutics to treat human diseases

The role microbes play in human health and the ability of synthetic biology to engineer microbial properties opens up new ways of treating disease. In this perspective, the authors describe the design and development of these living therapeutics.

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Mark R. Charbonneau, Vincent M. Isabella, Ning Li, Caroline B. Kurtz
Format: article
Langue:EN
Publié: Nature Portfolio 2020
Sujets:
Q
Accès en ligne:https://doaj.org/article/26fba4ca08df4eda919a1a6132d74277
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!